In the current study, we confirmed that CDC20 was upregulated at both mRNA and protein levels in MCL patients and MCL cell lines possessing either mutant p53 (Jeko and Mino) or wild type p53 (Z138 and JVM2). The gene discussed is CDC20; the disease is mantle cell lymphoma.